VINCENT KLOMPS: Open Payments
NPI 1407378011 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 68 payments from 15 companies in 2025. Trend: 2023 $1,049 · 2024 $677 · 2025 $1,360
Food & beverage: $1,257Education: $103
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $366 |
| Janssen Biotech, Inc. | 23 | $307 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $179 |
| Regeneron Healthcare Solutions, Inc. | 3 | $157 |
| ABBVIE INC. | 5 | $103 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Botanix SB Inc | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| UCB, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
Products named: DUPIXENT, TREMFYA, LIBTAYO, SKYRIZI, ILUMYA, Zoryve, SOFDRA, COSENTYX.
Industry payments across SC — which companies pay providers there.
